Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NYMX | AZN | AMGN | GILD | VRTX |
| Company | Nymox Pharm Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2200 | 95.18 | 337.76 | 124.08 | 481.51 |
| High | 0.2200 | 95.95 | 341.46 | 125.11 | 485.69 |
| Low | 0.1827 | 94.43 | 331.09 | 120.76 | 476.84 |
| Latest | 0.2000 | 94.58 | 331.23 | 120.74 | 474.11 |
| Change | -0.0490 | -0.58 | -10.41 | -3.61 | -10.04 |
| % Change | -19.68% | -0.61% | -3.05% | -2.90% | -2.07% |
| Volume | 932,700 | 2,879,967 | 1,182,681 | 2,928,341 | 639,742 |
| 20-Day Average Volume | 309,280 | 4,664,087 | 2,726,447 | 6,240,954 | 1,245,926 |
| Previous Close | 0.2490 | 95.16 | 341.64 | 124.35 | 484.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3282 | 92.00 | 327.47 | 122.40 | 457.54 |
| 20-Day Raw Stochastic | 12.57% | 73.86% | 68.82% | 42.07% | 83.45% |
| 20-Day Relative Strength | 33.51 | 62.81 | 54.52 | 48.35 | 63.95 |
| Weighted Alpha | -62.47 | +44.95 | +27.13 | +29.29 | +19.11 |
| Today's Opinion | 56% Sell | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 32% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.98% since 06/28/23 | +2.93% since 12/31/25 | +1.89% since 12/31/25 | -1.17% since 12/31/25 | +5.57% since 12/31/25 |
| Low | 0.1688 on 06/30/23 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 0.3500 on 07/03/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | -50.94% since 06/06/23 | +3.66% since 12/08/25 | +3.82% since 12/08/25 | +0.10% since 12/08/25 | +8.28% since 12/08/25 |
| Low | 0.1688 on 06/30/23 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 433.81 on 12/10/25 |
| High | 0.4170 on 06/16/23 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -43.80% since 04/06/23 | +10.82% since 10/08/25 | +13.19% since 10/08/25 | +2.59% since 10/08/25 | +13.65% since 10/08/25 |
| Low | 0.1688 on 06/30/23 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 0.4950 on 05/08/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -50.73% since 01/06/23 | +35.13% since 07/08/25 | +12.29% since 07/08/25 | +9.23% since 07/08/25 | +2.63% since 07/08/25 |
| Low | 0.1688 on 06/30/23 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 0.5299 on 02/16/23 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,103 | 295,134,176 | 183,966,656 | 154,278,560 | 122,838,048 |
| Shares Outstanding, K | 90,515 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -6,580,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -1,390,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.64 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/12/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 08/21/23 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.78 | 15.10 | 14.82 | 30.59 |